PAA 2.38% 20.5¢ pharmaust limited

Ann: Resignation of Dr Michael Thurn & appointment of John Clark, page-44

  1. 2,387 Posts.
    lightbulb Created with Sketch. 1473
    Very unlikely, that would be insider trading.

    Most upseting after the great forward drive he's given PharmAust. Agree with those who say it cannot be the science as that would be material information that must be published. Personal and family reasons could be anything. If it's a massive disagreement over strategy I'd like to know it.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.